TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS

• 收藏
• 分享

专利权人:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

发明人:

CHANDY, GEORGE, K.,UPADHAYAY, SANJEEV, KUMAR,WANG, PING, H.,CORSI, PAOLO, SASSONE,MAHAN, KRISTIN, LYNN-ECKEL,IADONATO, SHAWN,MUKERGEE, JOSEPH,MIRBOLOOKI, REZA, M.

申请号：

SG11201401193X

公开号：

SG11201401193XA

申请日:

2012.10.02

申请国别(地区):

SG

年份:

2014

代理人:

摘要：

Activation of brown adipose tissue, treatment of obesity and/or treatment of obesity-related disorders in human or non-human animal subjects by administering to the subject a potassium channel inhibiting agent. The potassium channel inhibiting agent may comprise ShK toxin or a modified ShK toxin. Examples of modified ShK toxins include ShK-186.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/